Aethlon Medical (AEMD) Net Equity Issued and Repurchased (2010 - 2026)

Aethlon Medical's Net Equity Issued and Repurchased history runs 17 years deep, the most recent figure standing at -$848477.0 for Q1 2026.

• Quarterly Net Equity Issued and Repurchased fell 24.68% year-over-year to -$848477.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.9 million (up 46.72% YoY) and the FY2026 annual result came in at $6.9 million, up 46.72% from the prior year.
• Net Equity Issued and Repurchased was -$848477.0 for Q1 2026 at Aethlon Medical, down from $4.0 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $8.3 million in Q3 2022 and bottomed at -$848477.0 in Q1 2026.
• A 5-year average of $2.0 million and a median of $1.1 million in 2023 frame the typical range for Net Equity Issued and Repurchased.
• Annual changes were most pronounced in 2024 — Net Equity Issued and Repurchased jumped 888.95% — and 2025, when it sank 1467.52%.
• Aethlon Medical's Net Equity Issued and Repurchased stood at $8.3 million in 2022, then tumbled by 97.76% to $186501.0 in 2023, then soared by 888.95% to $1.8 million in 2024, then soared by 117.17% to $4.0 million in 2025, then sank by 121.18% to -$848477.0 in 2026.
• Business Quant data shows AEMD's Net Equity Issued and Repurchased at -$848477.0 in Q1 2026, $4.0 million in Q4 2025, and $3.7 million in Q3 2025.